Prêle, C.M.; Iosifidis, T.; McAnulty, R.J.; Pearce, D.R.; Badrian, B.; Miles, T.; Jamieson, S.E.; Ernst, M.; Thompson, P.J.; Laurent, G.J.;
et al. Reduced SOCS1 Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155. Biomedicines 2021, 9, 498.
https://doi.org/10.3390/biomedicines9050498
AMA Style
Prêle CM, Iosifidis T, McAnulty RJ, Pearce DR, Badrian B, Miles T, Jamieson SE, Ernst M, Thompson PJ, Laurent GJ,
et al. Reduced SOCS1 Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155. Biomedicines. 2021; 9(5):498.
https://doi.org/10.3390/biomedicines9050498
Chicago/Turabian Style
Prêle, Cecilia M., Thomas Iosifidis, Robin J. McAnulty, David R. Pearce, Bahareh Badrian, Tylah Miles, Sarra E. Jamieson, Matthias Ernst, Philip J. Thompson, Geoffrey J. Laurent,
and et al. 2021. "Reduced SOCS1 Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155" Biomedicines 9, no. 5: 498.
https://doi.org/10.3390/biomedicines9050498
APA Style
Prêle, C. M., Iosifidis, T., McAnulty, R. J., Pearce, D. R., Badrian, B., Miles, T., Jamieson, S. E., Ernst, M., Thompson, P. J., Laurent, G. J., Knight, D. A., & Mutsaers, S. E.
(2021). Reduced SOCS1 Expression in Lung Fibroblasts from Patients with IPF Is Not Mediated by Promoter Methylation or Mir155. Biomedicines, 9(5), 498.
https://doi.org/10.3390/biomedicines9050498
